R3i.vc · The capital arm of R3i
R3i.vc invests globally in IP-based deep technology companies, with a standing mandate across climate, water and health.
01 · Strategy
Deep technology, concentrated where research breakthroughs are becoming market infrastructure — with a standing mandate across climate, water and health. Strategic AI, autonomy and frontier infrastructure are the enabling layers; climate, water and health are where they are underwritten and deployed.
Foundational models, data infrastructure, enterprise intelligence and enabling technologies.
Autonomous systems, robotics, aerospace, security and mission-critical technologies.
Advanced industrial systems, energy, mobility, computation and the infrastructure to deploy frontier technologies at scale.
02 · Parameters
| Stage | Seed and Series A, with reserves for follow-on - Secondaries - Pre-IPO Growth Equities |
|---|---|
| Geography | Global — Asia-Pacific, Europe and the Americas |
| Instrument | Funds, direct investments, syndicated vehicles, and a curated private-secondaries dealdesk |
| Cheque size | Stated in offering documents |
| Fund size & terms | Stated in offering documents |
Terms are indicative until confirmed in the confidential offering documentation available to qualified investors.
03 · Funds
The vehicles open today, one mandate discipline. Further vehicles are described in offering documentation and listed here once confirmed. Each is offered only to qualified investors through confidential documentation.
The secondaries vehicle: institutional access to large-cap private secondaries in frontier technology, sourced and underwritten through the R3i DealDesk. The desk →
The venture fund for the standing mandate — climate, water and health. Target size stated in offering materials.
Open — execution desk, not a fund
The curated execution desk for large-cap private secondaries. How the desk works →
Vehicle status is stated as at 2 August 2026. Additional vehicles are described in offering documentation and are listed here once their status is confirmed. Target size and hard cap are stated separately from first close and actual commitments in the offering documentation. US interests, where offered, are offered in reliance on the Regulation D private-placement exemption to accredited investors only. Nothing on this page is an offer of securities.
04 · R3i DealDesk
The R3i DealDesk is R3i's execution desk for large-cap private secondaries in frontier technology — reserved for sovereign, institutional and family-office capital. Inventory is originated at source and screened at the gate; broker-chain blocks, stacked fees and unverified counterparties do not pass.
The desk is active across the categories institutional buyers expect — frontier AI model developers, defence autonomy, data infrastructure, consumer platforms and space. Mandate names are disclosed to qualified counterparties under confidentiality, after KYC and compliance clearance.
The desk operates through R3i Ventures Pte. Ltd. in Singapore, with R3i Inc. (Delaware) as the management and origination company. The R3i entities originate, structure and introduce; US securities execution runs chaperoned through Finalis Securities LLC, a registered broker-dealer and member FINRA/SIPC.
Access follows KYC and compliance clearance, under confidentiality. Mandates are never named on this website. Speak with the desk →
05 · Portfolio
Fund investments, reported separately from the R3i DealDesk — where R3i acts as intermediary, not holder.
Companies transforming physical, energy and resource systems.
MGA Thermal · Flexpenser
Companies applying AI and data to critical industries.
Marlee
Moving diagnosis and care from reactive to predictive.
ViewMind · Meracle Health · Asima Health · StratifiCare · Soliddd
Quantum, semiconductors, advanced materials.
Quantum Brilliance
Selected holdings across R3i's venture and secondaries vehicles, shown for illustration of strategy. Inclusion is not a representation of performance; advisory and programme relationships are not presented as fund holdings.
06 · Alongside R3i
Two kinds of names, proving two different things.
Connect the Drops · Hatcher · Omusubi Capital · Microsoft for Startups · Nvidia · Enterprise Singapore · Plug and Play
United States (Delaware) · Luxembourg · Singapore
07 · Team
Full biographies available to qualified LPs on request.
Founding GP & Managing Partner. Deal origination, structuring and LP relationships across the platform.
Chief Scientific Officer. Professor of Computer Science (U. Illinois); technical and IP diligence.
Head of International Affairs & IR. Investor relations, risk and EU regulatory affairs.
Fund Operations & Compliance. Compliance oversight and the chaperoned execution workflow.
Financial Analyst. Deal modelling, fee-waterfall structuring and counterparty diligence.
Financial Analyst. Analysis, capital calls and audit liaison.
Graphic Designer. Brand and product design across the platform.
Advisors
Computer Science. Professor Emeritus of Engineering, University of Illinois; former Provost & Dean of Engineering, UIUC.
Biotech. Former Chief Editor, British Medical Journal · Wiley · Oxford University Press.
Artificial Intelligence. PhD, Bristol. Thirty years building AI systems; founder of four AI companies, professor at UC Berkeley, ex-AT&T Research.
Compute. 30+ years in telecom and ICT; VP Alliances, Etisalat Group (Saudi Arabia); Chief Marketing & Partnership Officer, TM ONE at Telekom Malaysia. Former Dhiraagu; former Celcom.
MedTech. Health Economics & Outcomes Research consultant; leads the Bermuda Chapter and Health Syndicate, TRIUM Angels. Board member, Centennial Bermuda Foundation.
Legal. Partner, Ponte Andrade & Casanova; Venezuelan oil & gas, mining and infrastructure law. Former partner, Norton Rose Fulbright; former Head of Special Assets, CAF — Development Bank of Latin America.
IP. Co-founder, Gracenote; AI, compliance and regulatory-technology law.
Water. Founder, Mitidaption and Our Future Water; author of Climate Resilient Water Resources Management and the Climate Resilient Societies series (Palgrave Macmillan).
Human Performance. Olympic gold medallist; elite-performance transition and coaching.
FinTech. GP, FinMirai; board member, Rakbank and Human AI; former founding Chief Innovation Officer, DBS Bank.
Data Management. Founder, Protego VC Studio (LeftShield, EDO, Certen); helped establish the DataOps category across APAC with Delphix, and led Actifio's APAC growth prior to its acquisition by Google.
Intellectual Property. Founder & CEO, Phi Ventures; global IP commercialisation, brand protection and supply-chain security. Former Director of Brand Protection APAC, Fitbit; Director of IP Protection, Dolby. Author, Protecting The Brand: Counterfeiting and Grey Markets.
Secondaries desk network
Through Finalis Securities LLC, R3i accesses a global network of broker-dealers and merchant banks, alongside direct partnerships with specialist secondary desks, investment banks and advisory firms.
Responsible investment & compliance
R3i's standing mandate — climate, water and health — is itself an ESG lens: capital is directed toward technologies that reduce physical, resource and health risk. Environmental, social and governance factors are assessed as part of diligence on every prospective investment and reviewed at portfolio level on an ongoing basis.
R3i maintains a risk-based Anti-Money Laundering and Know-Your-Customer policy across its entities, applied to investors, counterparties and transaction partners before capital moves. KYC/AML clearance is a precondition of access to the R3i DealDesk and to any fund commitment.
Conflicts & regulatory architecture
R3i can act as originator, advisor, investor, SPV sponsor and venture creator across the platform. That range is structural to the model, and it is disclosed on every mandate: counterparties are told upfront whether R3i is acting as principal or as agent, and any transaction where R3i or a related party holds a position is flagged before terms are agreed.
Fee arrangements — origination, structuring, management and carry, where applicable — are disclosed in priority order in the offering or engagement documentation, not layered silently. Valuations on related-party and secondary transfers are subject to independent review triggers rather than sponsor mark alone. Capital allocation across concurrent mandates follows a written policy, and R3i's Investment Committee members recuse themselves from decisions where they hold a personal or related-party interest.
Entity roles and registrations are mapped by jurisdiction and available to qualified counterparties under confidentiality as part of diligence.
08 · Contact
Offering materials are available to accredited investors under confidentiality. Start a conversation below — correspondence runs on the r3iventures.com domain.
